Composite micro-ecological regulator mainly containing stachyose

文档序号:1030136 发布日期:2020-10-30 浏览:30次 中文

阅读说明:本技术 一种以水苏糖为主的复合微生态调节剂 (Composite micro-ecological regulator mainly containing stachyose ) 是由 任伦 黄南 于 2020-07-30 设计创作,主要内容包括:本发明公开了一种以水苏糖为主的复合微生态调节剂,涉及固体饮料、保健食品及药品技术领域;为了解决直接添加双歧杆菌粉、嗜酸乳杆菌粉,其抗逆性和环境耐受性不高问题;具体以下组分原料:水苏糖、棉子低聚糖、低聚果糖、益生菌和辅料,水苏糖、棉子低聚糖、低聚果糖的重量份配比为2:1:1;所述益生菌为嗜酸乳杆菌、发酵乳杆菌、短双歧杆菌、干酪乳杆菌。本发明选取微生物为芯材,被包裹的益生菌仅能在动物肠道中释放,能够抵御宿主机体内高胃酸和胆盐等不利环境,与未包裹的复合益生菌相比,采用微胶囊制备技术,微生物复合菌剂的抗逆性、环境耐受性大幅度提高,更加便于其在肠道环境下功能的发挥,更便于运输和长期保存。(The invention discloses a composite micro-ecological regulator mainly comprising stachyose, and relates to the technical field of solid beverages, health-care foods and medicines; aiming at solving the problem that the stress resistance and the environmental tolerance are not high due to the direct addition of bifidobacterium powder and lactobacillus acidophilus powder; the concrete raw materials of the following components: stachyose, cotton seed oligosaccharide, fructo-oligosaccharide, probiotics and auxiliary materials, wherein the weight ratio of the stachyose to the cotton seed oligosaccharide to the fructo-oligosaccharide is 2: 1: 1; the probiotic bacteria are Lactobacillus acidophilus, Lactobacillus fermentum, Bifidobacterium breve and Lactobacillus casei. According to the invention, the microorganism is selected as a core material, the coated probiotics can be released only in animal intestinal tracts, and adverse environments such as high gastric acid, bile salt and the like in a host can be resisted.)

1. A composite micro-ecological regulator taking stachyose as a main component is characterized by comprising the following raw materials: stachyose, cotton seed oligosaccharide, fructo-oligosaccharide, probiotics and auxiliary materials, wherein the weight ratio of the stachyose to the cotton seed oligosaccharide to the fructo-oligosaccharide is 2: 1: 1.

2. the complex micro-ecological regulator of claim 1, wherein the probiotic is a mixture of one or more of lactobacillus acidophilus, lactobacillus fermentum, bifidobacterium breve, lactobacillus casei, lactobacillus reuteri, lactobacillus raman, bifidobacterium longum, bifidobacterium breve, bifidobacterium bifidum, bifidobacterium infantis, bifidobacterium lactis, bifidobacterium adolescentis, bifidobacterium thermophilum, bacillus subtilis, saccharomyces boulardii and bifidobacterium rhamnosus.

3. The compound micro-ecological regulator with stachyose as main component as claimed in claim 2, wherein the viable count ratio of the probiotics is that the viable count ratio of lactobacillus fermentum and bifidobacterium breve is 109Per g, Bifidobacterium lactisAnd Bifidobacterium rhamnosum has a bacterial count of 108(iv)/g, the number of Lactobacillus reuteri and Bifidobacterium infantis is 105/g。

4. The complex micro-ecological regulator with stachyose as the main ingredient as claimed in claim 3, wherein the probiotic is microencapsulated micro-ecological probiotic powder, the core material is microorganism, and the preparation method of the microcapsule of the probiotic comprises the following processes:

s11: uniformly mixing one or more probiotics serving as core materials with wall materials to obtain a mixture;

s12: and (3) carrying out low-temperature spray drying on the mixture, and mixing the mixture with the rest components to obtain the microencapsulated microecological probiotic powder.

5. The composite microecological regulator with stachyose as the main component according to claim 4, wherein the wall material is 25% -55% propylene glycol alginate solution.

6. The composite microecological regulator with stachyose as the main component of claim 5, wherein the volume ratio of the core material to the wall material is 0.06: 1.

7. the compound micro-ecological regulator with stachyose as the main ingredient as claimed in any one of claims 1-6, wherein the adjuvant is one of correctant, binder, lubricant, filler and disintegrant, and the adjuvant is blueberry extract.

8. The complex microecological regulator based on stachyose as claimed in claim 1, wherein the preparation method of the complex microecological regulator based on stachyose comprises the following steps:

s1: mashing blueberry into paste according to the ratio of the raw materials, pouring the pasty blueberry raw material into a stirrer, adding stachyose, raffinose, fructo-oligosaccharide and traditional Chinese medicine extract, and stirring for 5 min;

s2: pouring the stirred raw materials into a drying oven for drying treatment, wherein the drying temperature is 60-90 ℃, and the drying time is 2-4 h;

s3: pouring the dried raw materials into a pulverizer to be pulverized, and sieving the pulverized raw materials with a 100-mesh sieve;

s4: uniformly mixing the raw material treated in the step S3 with microencapsulated microecological probiotic powder to obtain a product;

s5: pouring the product into a bagging machine for bagging treatment, controlling the weight of each bag to be 5g, packaging each box into 15-20 bags, and packaging and warehousing after the inspection is qualified.

9. The complex microecological modulator with stachyose as main component of claim 8, wherein the product is instant lyophilized powder.

Technical Field

The invention relates to the technical field of solid beverages, health-care foods and medicines, in particular to a composite micro-ecological regulator taking stachyose as a main component.

Background

The intestinal flora is considered to be an important endocrine organ of the human body, the health condition of the human body is closely related to the intestinal flora, and the influence of the prebiotic composition on the intestinal flora and the host is summarized as follows: (1) regulating flora structure, proliferating beneficial flora, and inhibiting pathogenic bacteria and diarrhea; (2) the proliferated beneficial bacteria can stimulate the activity of intestinal immunocytes, thereby enhancing the immunity and disease resistance of organisms and reducing the risk of cancer occurrence; (3) the enzyme secreted by the beneficial bacteria can decompose the prebiotics to generate nutrient substances, and can increase the absorption of the host to the nutrition; (4) the pH value in the intestinal tract is reduced, and the mineral absorption function is promoted; (5) relieving lactose intolerance, increasing defecation, and preventing and treating constipation; (6) regulating blood lipid and cholesterol metabolism, and lowering blood pressure; (7) reduce the probability of dental caries and avoid blood sugar rise. However, the prebiotic products in the prior art have single function and monotonous variety, and less functional foods can be selected by people.

Through search, the Chinese patent with the application number of CN02145700.X discloses an intestinal microecological regulator, which belongs to the field of microecological preparations. Mainly comprises bifidobacterium powder, lactobacillus acidophilus powder and stachyose, and comprises the following components in parts by weight: stachyose (containing raffinose) 10-90 wt%, bacterial powder 5-75 wt% and additive 0-30 wt%. The intestinal micro-ecological regulator in the above patent has the following disadvantages: the bifidobacterium powder and the lactobacillus acidophilus powder are directly added into the regulator, and the stress resistance and the environmental tolerance are not high.

Disclosure of Invention

The invention aims to solve the defects in the prior art and provides a composite microecological regulator mainly comprising stachyose.

In order to achieve the purpose, the invention adopts the following technical scheme:

a composite microecological regulator mainly comprising stachyose comprises the following raw materials: stachyose, cotton seed oligosaccharide, fructo-oligosaccharide, probiotics and auxiliary materials, wherein the weight ratio of the stachyose to the cotton seed oligosaccharide to the fructo-oligosaccharide is 2: 1: 1.

preferably: the probiotic bacteria is one or more of Lactobacillus acidophilus, Lactobacillus fermentum, Bifidobacterium breve, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus raman, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium bifidum, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bacillus subtilis, Saccharomyces boulardii and Bifidobacterium rhamnosum.

Preferably: the viable count ratio of the probiotics is that the viable count ratio of the lactobacillus fermentum and the bifidobacterium breve is 109(10) the number of Bifidobacterium lactis and Bifidobacterium rhamnosum8(iv)/g, the number of Lactobacillus reuteri and Bifidobacterium infantis is 105/g。

Preferably: the preparation method of the probiotic microencapsulation comprises the following steps:

s11: uniformly mixing one or more probiotics serving as core materials with wall materials to obtain a mixture;

s12: and (3) carrying out low-temperature spray drying on the mixture, and mixing the mixture with the rest components to obtain the microencapsulated microecological probiotic powder.

Preferably: the wall material is 25% -55% of propylene glycol alginate solution.

Preferably: the volume ratio of the core material to the wall material is 0.06: 1.

preferably: the auxiliary material is one of a flavoring agent, an adhesive, a lubricant, a filling agent and a disintegrating agent, and the auxiliary material is a blueberry extract.

Preferably: the preparation method of the composite micro-ecological regulator mainly comprising stachyose comprises the following steps:

s1: mashing blueberry into paste according to the ratio of the raw materials, pouring the pasty blueberry raw material into a stirrer, adding stachyose, raffinose, fructo-oligosaccharide and traditional Chinese medicine extract, and stirring for 5 min;

s2: pouring the stirred raw materials into a drying oven for drying treatment, wherein the drying temperature is 60-90 ℃, and the drying time is 2-4 h;

s3: pouring the dried raw materials into a pulverizer to be pulverized, and sieving the pulverized raw materials with a 100-mesh sieve;

s4: uniformly mixing the raw material treated in the step S3 with microencapsulated microecological probiotic powder to obtain a product;

s5: pouring the product into a bagging machine for bagging treatment, controlling the weight of each bag to be 5g, packaging each box into 15-20 bags, and packaging and warehousing after the inspection is qualified.

Preferably: the product is instant freeze-dried powder.

The invention has the beneficial effects that:

1. the microbial composite inoculant is prepared by a microcapsule preparation technology, so that the stress resistance and the environmental tolerance of the microbial composite inoculant are greatly improved, the microbial composite inoculant is more convenient to exert functions in the intestinal environment, and is more convenient to transport and store for a long time.

2. Stachyose, blueberry extract, probiotics and chicken's gizzard-membrane hydrolyzed peptide are combined to serve as raw materials of the health-care food to adjust intestinal microecology, so that the reproduction of helicobacter pylori can be inhibited in an auxiliary mode, gastric mucosa damaged by alcohol can be repaired, the repairing effect is good, no side effect exists, and the health-care food can be eaten for a long time.

3. Stachyose and soluble dietary fiber or endothelium corneum gigeriae galli polypeptide and trace element zinc are added, and the synergistic effect of stachyose and soluble dietary fiber or endothelium corneum gigeriae galli polypeptide and trace element zinc can effectively improve the intestinal flora structure and the intestinal immunity, and has remarkable effects on promoting chronic colitis and irritable bowel syndrome.

4. Stachyose can obviously proliferate beneficial bacteria represented by bifidobacterium in intestinal tract, inhibit the growth of harmful bacteria, promote the digestion and absorption of protein, promote the synthesis of B vitamins and optimize the immunity of a host, and the like, and promote the secretion of protease, amylase, lipase and the like by the beneficial bacteria.

Drawings

FIG. 1 is a schematic flow chart of an embodiment 1 of a stachyose-based composite microecological regulator provided by the present invention;

fig. 2 is a schematic flow chart of an embodiment 2 of the stachyose-based composite microecological regulator provided by the invention.

Detailed Description

The technical solution of the present patent will be described in further detail with reference to the following embodiments.

Reference will now be made in detail to embodiments of the present patent, examples of which are illustrated in the accompanying drawings, wherein like or similar reference numerals refer to the same or similar elements or elements having the same or similar function throughout. The embodiments described below with reference to the drawings are exemplary only for the purpose of explaining the present patent and are not to be construed as limiting the present patent.

In the description of this patent, it is to be understood that the terms "center," "upper," "lower," "front," "rear," "left," "right," "vertical," "horizontal," "top," "bottom," "inner," "outer," and the like are used in the orientations and positional relationships indicated in the drawings for the convenience of describing the patent and for the simplicity of description, and are not intended to indicate or imply that the referenced devices or elements must have a particular orientation, be constructed and operated in a particular orientation, and are not to be considered limiting of the patent.

In the description of this patent, it is noted that unless otherwise specifically stated or limited, the terms "mounted," "connected," and "disposed" are to be construed broadly and can include, for example, fixedly connected, disposed, detachably connected, disposed, or integrally connected and disposed. The specific meaning of the above terms in this patent may be understood by those of ordinary skill in the art as appropriate.

9页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:金骨莲胶囊在制备抗乳腺癌药物中的应用

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!